Mycobacterium kansasii infections in patients positive for human immunodeficiency virus. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Mycobacterium kansasii infections in patients positive for human immunodeficiency virus.

Rev Infect Dis. 1991 Sep-Oct;13(5):789-96. Unique Identifier : AIDSLINE MED/92073788
Carpenter JL; Parks JM; Department of Internal Medicine, University of Texas Southwestern; Medical Center, Dallas 75235-8889.

Abstract: The experience with Mycobacterium kansasii infections in patients who are infected with human immunodeficiency virus (HIV) at Parkland Memorial Hospital in Dallas is presented, and the literature on such infections is reviewed. The absolute and relative paucity of reports of M. kansasii infections in HIV-positive patients is emphasized. M. kansasii infections in HIV-positive patients are classified as either pulmonary or disseminated. Evidence of the lack of therapeutic response in patients with disseminated infections and of the potential for therapeutic response in patients with infections limited to the lung is reviewed and documented. Other unresolved diagnostic and therapeutic issues concerning M. kansasii infections in HIV-positive patients are reviewed.
Keywords: Adult Bacteremia/MICROBIOLOGY Case Report Human HIV Infections/*COMPLICATIONS Lung/MICROBIOLOGY/PATHOLOGY Male Middle Age Mycobacterium Infections, Atypical/*COMPLICATIONS Mycobacterium, Atypical/ISOLATION & PURIF Retrospective Studies Tuberculosis, Pulmonary/*COMPLICATIONS JOURNAL ARTICLE

KWDadultbacteremia/microbiologycasereporthumanhivinfections/KWDcomplicationslung/microbiology/pathologymalemiddleagemycobacteriuminfections,atypical/KWDcomplicationsmycobacterium,atypical/isolation&purifretrospectivestudiestuberculosis,pulmonary/KWDcomplicationsjournalarticle
920330
M9230530

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .